ACOL .0007, sales increasing:
Letter To Shareholders: From Curt Fairbrother, Ceo [Market News Publishing (US)]
ACOLOGY INC
ACOLOGY INC ("ACOL,PNCRD-0") - Letter To Shareholders: From Curt Fairbrother, Ceo
Dear Acology Shareholders:
The past quarter has been an extremely positive time for Acology Inc. and we would like to bring you up-to-date on recent company activities.
Acologya(TM)s note has recently been acquired by a friendly third party, who is very interested in the health and growth of Acology. The Companya(TM)s products and sales continue to increase monthly and maintain overall gains. In the last 90 days company revenues have continued to climb and the end of August 2015 closed the best month in the companya(TM)s history. Acologya(TM)s substantial growth in the last calendar quarter is evident in our 10-Q report. Acology revenues have more than quadrupled during this time over the same period last year. Revenue increases over the past two quarters have exceeded 400%.
Due to increasing customer demand, Acology has introduced a new larger 40 dram sized Medtainer. With the addition of this new larger size, it will offer perfect compliment to the flagship 20 dram Medtainer which is now in world-wide use.
Safe Harbor Statement
This Press Release may contain certain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. The Company has tried, whenever possible, to identify these forward-looking statements using words such as "anticipates," "believes," "estimates," "expects," "plans," "intends," "potential" and similar expressions. These statements reflect the Company's current beliefs and are based upon information currently available to it. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements.
Acology Inc. and D&C Distributors are located in their new production and distribution facility at 1630 Commerce St. Corona, California, 92880. Acology trades on the OTC under the call letters ACOL. The companya(TM)s email is www.Acologyinc.com. Please send inquiries to info@acologyinc.com or call (844) ACOLOGY (844-226-5649)
Social Media:
Facebook.com/TheMedtainer
Twitter.com/TheMedtainer
Thank you
Curt Fairbrother, CEO
Acology Inc.
Acology Inc. E-mail: info@acologyinc.com
AI
